Sign Up to like & get
recommendations!
0
Published in 2018 at "International Journal of Impotence Research"
DOI: 10.1038/s41443-018-0046-2
Abstract: The phosphodiesterase-5 inhibitors (PDE5Is) are the first-line treatment option for men with erectile dysfunction (ED), with alprostadil considered a second-line choice. Consideration has to be given to patients who fail these treatments and what their…
read more here.
Keywords:
combination;
treatment;
erectile dysfunction;
therapy ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "Medicine"
DOI: 10.1097/md.0000000000023507
Abstract: Abstract Background: The pathogenesis of diabetic peripheral neuropathy is more complex and it is not yet clear, but studies have shown that microangiopathy and oxidative stress responses are closely related to their pathogenesis. At present,…
read more here.
Keywords:
treatment diabetic;
lipoic acid;
treatment;
alpha lipoic ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Andrologia"
DOI: 10.1111/and.13480
Abstract: No study has yet been done to evaluate topical alprostadil as a less invasive alternative vasoactive agent for Penile Dynamic Duplex Ultrasonography (PDDU) in the diagnosis of erectile dysfunction. The main aim of our study…
read more here.
Keywords:
penile dynamic;
dynamic duplex;
topical alprostadil;
intracavernous injection ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2019 at "Vascular"
DOI: 10.1177/1708538118816267
Abstract: Objectives To determine the indications for the use, potential benefits, and adverse reactions of alprostadil in a group of Colombian patients. Methods A retrospective cross-sectional study was conducted in patients diagnosed with critical limb ischemia…
read more here.
Keywords:
patients severe;
use intravenous;
ischemia;
alprostadil patients ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Frontiers in Cardiovascular Medicine"
DOI: 10.3389/fcvm.2022.965364
Abstract: Background The optimum therapy for coronary slow flow phenomenon (CSFP) stays debatable. This study compared the effectiveness of alprostadil with isosorbide dinitrate in alleviating angina episodes in CSFP patients. Methods In this prospective, randomized controlled…
read more here.
Keywords:
angina episodes;
isosorbide dinitrate;
alprostadil;
dinitrate ... See more keywords